PETAL Consortium is pleased to announce it has received an educational grant from Acrotech Biopharma Inc.—a global pharmaceutical company dedicated to developing innovative medications—to support the creation of PETAL’s patient education portal, Patient Education and Access to Research in Lymphoma (PEARL).

PEARL will serve as a comprehensive resource for individuals affected by T-cell lymphoma, offering accessible information on the disease, answers to frequently asked questions, and details about clinical trials. The portal will also feature expert videos from PETAL’s principal investigators, along with personal stories from patients sharing their journeys through diagnosis, treatment, and survivorship.